TrialThe lancet. HIV2026

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, VRC07-523LS, and PGT121.414.LS infused intravenously or subcutaneously (HVTN 140/HPTN 101 part B): a phase 1, randomised trial.

Sharana Mahomed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.